Skip to main content

Military Health System

Development of WRAIR’s Pan-Coronavirus Vaccine Shows Promise

Image of A vial of spike ferritin nanoparticle WRAIR's COVID-19 vaccine. A vial of spike ferritin nanoparticle (SpFN), WRAIR’s COVID-19 vaccine. Built on a ferritin platform, the vaccine offers a flexible approach to targeting multiple variants of the virus that causes COVID-19 and potentially other coronaviruses as well (Photo by: Mike Walters, Walter Reed Army Institute of Research).

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Coronavirus & the MHS Response | COVID-19 Vaccine Efforts

A series of recently published preclinical study results show that the Spike Ferritin Nanoparticle (SpFN) COVID-19 vaccine developed by researchers at the Walter Reed Army Institute of Research in Silver Spring, Maryland not only elicits a potent immune response but may also provide broad protection against SARS-CoV-2 variants of concern as well as other coronaviruses.

Scientists in WRAIR's Emerging Infectious Diseases Branch (EIDB) developed the SpFN nanoparticle vaccine, based on a ferritin platform, as part of a forward-thinking "pan-SARS" strategy that aims to address the current pandemic and acts as a first line of defense against variants of concern and similar viruses that could emerge in the future.

"The accelerating emergence of human coronaviruses throughout the past two decades and the rise of SARS-CoV-2 variants, including most recently Omicron, underscore the continued need for next-generation preemptive vaccines that confer broad protection against coronavirus diseases," said Dr. Kayvon Modjarrad, director of the Emerging Infectious Diseases Branch at WRAIR, co-inventor of the vaccine and the Army lead for SpFN. "Our strategy has been to develop a 'pan-coronavirus' vaccine technology that could potentially offer safe, effective and durable protection against multiple coronavirus strains and species."

Pre-clinical studies published today in Science Translational Medicine indicate that the SpFN vaccine protects non-human primates from disease caused by the original strain of SARS-CoV-2 and induces highly-potent and broadly-neutralizing antibody responses against major SARS-CoV-2 variants of concern including the SARS-CoV-1 virus that emerged in 2002.

SpFN entered Phase 1 human trials in April 2021. Early analyses, expected to conclude this month, will provide insights into whether SpFN's potency and breadth, as demonstrated in preclinical trials, will carry over into humans. The data will also allow researchers to compare SpFN's immune profile to that of other COVID-19 vaccines already authorized for emergency use.

"This vaccine stands out in the COVID-19 vaccine landscape," Modjarrad said. "The repetitive and ordered display of the coronavirus spike protein on a multi-faced nanoparticle may stimulate immunity in such a way as to translate into significantly broader protection."

WRAIR developed a secondary candidate vaccine, a SARS-CoV-2 Spike Receptor-Binding Domain Ferritin Nanoparticle (RFN) vaccine, which targets a smaller part of the coronavirus Spike protein than the SpFN vaccine. Results from a study, published recently in the Proceedings of the National Academy of Sciences, show that this vaccine potentially offers similar protection against an array of SARS-CoV-2 variants and SARS-CoV-1.

"The RFN vaccine candidate is more compact and has some natural advantages as we try to increase the immune response against multiple coronaviruses using a single vaccine platform, so it is still under consideration as part of our pan-coronavirus vaccine development pipeline," said Dr. Gordon Joyce, WRAIR structural biologist and vaccine co-inventor.

"The threat from COVID-19 continues as it evolves, and eventually there will be other emerging disease threats," said Dr. Nelson Michael, director of the Center for Infectious Diseases Research at WRAIR. "Our investment in developing a next generation vaccine is an important step towards getting ahead of COVID-19 and future disease threats."

You also may be interested in...

COVID-19: Bottom Line on Boosters

Infographic
9/19/2022
COVID-19: Bottom Line on Boosters

Bottom Line on Boosters: Stay up to date!

Recommended Content:

Coronavirus and the COVID-19 Vaccine

COVID-19 Novavax Vaccine

Infographic
8/18/2022
COVID-19 Novavax Vaccine

The Novavax COVID-19 Vaccine, Adjuvanated includes two doses, 21 days apart. Remember to mark your calendar and schedule time for your second dose.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Types of COVID-19 Vaccines

COVID-19 Vaccines

Infographic
8/18/2022
COVID-19 Vaccines

How COVID-19 Vaccines Work – There are three types of vaccines currently available: mRNA, subunit protein, and viral vector. Pfizer and Moderna are mRNA vaccine. Novavax is a subunit protein vaccine. Janssen is a viral vector vaccine. All products resemble a virus for the immune system to fight.

Recommended Content:

Coronavirus and the COVID-19 Vaccine

Vax Fax: Should I Get A COVID-19 Booster Shot?

Infographic
7/1/2022
Vax Fax: Should I Get A COVID-19 Booster Shot?

Some people may be eligible for a second booster shot. Share this graphic to communicate who may be eligible.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | COVID-19 Vax Facts

Mask Guidance

Infographic
7/1/2022
Mask Guidance

Mask Guidance for Department of Defense Facilities.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Prevent COVID-19

Anyone Can Get Vaccinated

Infographic
7/1/2022
Anyone Can Get Vaccinated

Now that anyone 6 months and older is eligible for a COVID-19 vaccine, share this graphic to encourage your community to get vaccinated.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Get to Know the COVID-19 Vaccines

Vax Facts: Should I Get a Second COVID-19 Booster Shot?

Infographic
7/1/2022
Vax Facts: Should I Get a Second COVID-19 Booster Shot?

This graphic outlines eligibility requirements for a first booster shot.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | COVID-19 Vax Facts

COVID-19 Testing and Treatment Main Graphic

Infographic
4/21/2022
COVID-19 Testing and Treatment Main Graphic

If your military hospital or clinic offers these antiviral treatments as part of the COVID-19 Test to Treat Initiative, use these graphics to promote your services to your beneficiaries.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | COVID-19 Treatment

COVID-19 Testing and Treatment Graphic 2

Infographic
4/21/2022
COVID-19 Testing and Treatment Graphic 2

If your military hospital or clinic offers these antiviral treatments as part of the COVID-19 Test to Treat Initiative, use these graphics to promote your services to your beneficiaries.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | COVID-19 Treatment

Make Guidance for DOD Facilities

Infographic
2/3/2022
Make Guidance for DOD Facilities

Mask Guidance for Department of Defense Facilities.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Prevent COVID-19

VAXFacts TRICARE coverage Vaccine

Infographic
2/3/2022
VAXFacts TRICARE coverage Vaccine

Will TRICARE cover the COVID-19 Vaccine? Yes. TRICARE offers the vaccine itself at no cost, but there may be a cost based on your plan for an office visit or if you require follow-on care.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | COVID-19 Vax Facts

Compromised Immune System

Infographic
2/3/2022
Compromised Immune System

Do you have a compromised immune system? The CDC recommends you get an additional primary dose of the mRNA COVID-19 vaccine.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Get to Know the COVID-19 Vaccines

VaxFacts: Should I get a booster?

Infographic
2/3/2022
VaxFacts: Should I get a booster?

Should I get a COVID-19 Booster Shot?

Recommended Content:

Coronavirus and the COVID-19 Vaccine | COVID-19 Vax Facts

Formulary Search Tool Buckslip (Page 1)

Infographic
1/27/2022
Formulary Search Tool Buckslip (Page 1)

The front side of a buck slip. Educates beneficiaries what the search tool is and what information can be found. Links to esrx.com/tform. Has three graphics grouped together on the right hand side.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Pharmacy Operations Toolkit

Formulary Search Tool Buckslip (Page 2)

Infographic
1/27/2022
Formulary Search Tool Buckslip (Page 2)

The back side of a buck slip. Educates beneficiaries what the search tool is and what information can be found. QR code is on the right and links to the search tool. The TRICARE and Express Scripts logo are on the bottom left.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Pharmacy Operations Toolkit
<< < 1 2 3 4 5  ... > >> 
Showing results 1 - 15 Page 1 of 6
Refine your search
Last Updated: December 28, 2021
Follow us on Instagram Follow us on LinkedIn Follow us on Facebook Follow us on Twitter Follow us on YouTube Sign up on GovDelivery